Eloxx Pharmaceuticals

1 Follower


We are a global biopharmaceutical company discovering and developing novel therapeutics for treating rare and ultra-rare premature stop codon diseases.

Greg Williams
Andi Leubitz
Senior Director of Clinical Operations
Martie Griffin
VP, Corporate Quality & Regulatory Affairs
Matthew Goddeeris
VP, Research
Neil S. Belloff
COO, General Counsel & Corporate Secretary
Rose Villandry
VP, Human Resources
Susan Schneider
SVP of Clinical Development, Ophthalmology
Thomas Haverty
Chief Medical Officer

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.